Actigraphy as an objective measure of performance status in patients with advanced cancer

被引：2
|
作者：
Pirl, William F.
Fujisawa, Daisuke
Stagl, Jamie
Eusebio, Justin
Traeger, Lara
El-Jawahri, Areej
Greer, Joseph A.
Temel, Jennifer S.
机构：
[1] Massachusetts Gen Hosp, Brookline, MA USA
[2] Keio Univ, Tokyo, Japan
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 29期
关键词：
D O I：
10.1200/jco.2015.33.29_suppl.62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Murakami, Kosuke
    Tobiume, Takako
    Suzuki, Ayako
    Mandai, Masaki
    Matsumura, Noriomi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (04) : 698 - 706
  • [42] Physical Activity Using a Wearable Device as an Alternative to Performance Status in Patients With Advanced Lung Cancer
    Ito, Kentaro
    Suzuki, Yuta
    Sakaguchi, Tadashi
    Fujiwara, Kentaro
    Nishii, Yoichi
    Yasui, Hiroki
    Taguchi, Osamu
    Hataji, Osamu
    JAMA ONCOLOGY, 2024, 10 (05) : 648 - 651
  • [43] Chemotherapy for advanced non-small cell lung cancer patients with performance status 2
    Blackhall, FH
    Bhosle, J
    Thatcher, N
    CURRENT OPINION IN ONCOLOGY, 2005, 17 (02) : 135 - 139
  • [44] Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response
    Laird, Barry J. A.
    Fallon, Marie
    Hjermstad, Marianne J.
    Tuck, Sharon
    Kaasa, Stein
    Klepstad, Pal
    McMillan, Donald C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2769 - +
  • [45] The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients
    D. Walsh
    S. Donnelly
    L. Rybicki
    Supportive Care in Cancer, 2000, 8 : 175 - 179
  • [46] Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status
    Hisamitsu Takaya
    Hidekatsu Nakai
    Kosuke Murakami
    Takako Tobiume
    Ayako Suzuki
    Masaki Mandai
    Noriomi Matsumura
    International Journal of Clinical Oncology, 2018, 23 : 698 - 706
  • [47] Discrepancy analysis of patient vs physician assessments of performance status in patients with advanced lung cancer
    Cashy, J
    Cella, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 754S - 754S
  • [48] SIPS as a Prognostic Biomarker within Performance Status in Advanced Lung Cancer Patients Treated with Pembrolizumab
    Chapple, S.
    Philips, I.
    Stares, M.
    MacKean, M.
    Barrie, C.
    Low, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S311 - S311
  • [49] The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients
    Mol, L.
    Ottevanger, P. B.
    Koopman, M.
    Punt, C. J. A.
    EUROPEAN JOURNAL OF CANCER, 2016, 66 : 138 - 143
  • [50] Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients
    Gillian Gresham
    Andrew E. Hendifar
    Brennan Spiegel
    Elad Neeman
    Richard Tuli
    B. J. Rimel
    Robert A. Figlin
    Curtis L. Meinert
    Steven Piantadosi
    Arvind M. Shinde
    npj Digital Medicine, 1
12345